Skip to main content

Table 2 Operative parameters and follow-up results

From: Laparoscopic total pelvic exenteration for pelvic malignancies: the technique and short-time outcome of 11 cases

Patient no.

Radical

Construction type

Operative time/min

Blood loss/ml

Pathological stage

PRM

Postoperative hospitalization/day

Postoperative complication (<30 days after surgery)

Postoperative complication (>30 days after surgery)

Follow-up time/month

pCRT

Outcome

1

Yes

Bricker’s procedure and sigmoidostomy (Miles procedure)

620

500

Rectum pT2N0M0 and Bladder pT2bN0M0

Negative

23

No

DVT (7 months)

7

No

Died of non-oncological disease (PE)

2

Yes

Cutaneous ureterostomy and sigmoidostomy (Miles procedure)

415

600

Prostate pT4N0M0

Negative

10

No

UTI (6 months)

12

No

Died of oncological recurrence

3

Yes

Bricker’s procedure and sigmoidostomy (Hartmann procedure)

574

420

Sigmoid pT3 N1M0

Negative

15

No

No

24

XELOX

Alive

4

Yes

Bricker’s procedure and anus preservation operation

616

650

Rectum pT4b N1M0

Negative

11

No

No

22

XELOX

Alive

5

Yes

Bricker’s procedure and sigmoidostomy (Hartmann procedure)

690

800

Rectum pT3N0M0 Bladder pT1N0M0

Negative

26

No

No

14

No

Alive

6

Yes

Bricker’s procedure and sigmoidostomy (Hartmann procedure)

660

400

Sigmoid pT4b N1M0

Negative

14

No

No

14

XELOX

Alive

7

Yes

Bricker’s procedure and anus preservation operation

515

600

Sigmoid pT4b N0M0

Negative

9

No

No

10

XELOX

Alive

8

Yes

Bricker’s procedure and sigmoidostomy (Miles procedure)

520

850

Rectum pT4b N0M0

Negative

16

No

No

7

No

Alive

9

Yes

Bricker’s procedure and anus preservation operation

610

400

Sigmoid pT4b N0M0

Negative

13

No

No

5

No

Alive

10

Yes

Cutaneous ureterostomy and sigmoidostomy (Hartmann procedure)

450

200

Sigmoid pT4b N1M0

Negative

11

No

UTI

5

No

Alive

11

Yes

Cutaneous ureterostomy and sigmoidostomy (Miles procedure)

547

600

Rectum pT4b N1M0

Negative

20

Ileus

Ileus

2

XELOX

Alive

Mean

  

565.2

547.3

  

15.3

  

11.1

  
  1. pCRT postdischarge chemoradiotherapy, XELOX capecitabine + oxaliplatin, PE pulmonary embolism, PRM pathological resection margin, DVT deep vein thrombosis